Ditans

Lasmiditan, sold under the brand name Reyvow, is a medication used to treat migraines. It is not useful for prevention. The drug is taken by mouth.

Alniditan (, ; developmental code name R-91274) is a selective serotonin 5-HT1B and 5-HT1D receptor agonist with migraine-preventive effects which was never marketed. It was under development for treatment of migraine via subcutaneous injection in the 1990s and reached phase 3 clinical trials for this indication prior to the discontinuation of its development.